Key result
ML-based CT-FFR achieves ~0.97 AUC in diffuse CAD but shows no association with major cardiovascular events.
Why the study?
The performance of computed tomography-derived fractional flow reserve (CT-FFR) in diffuse coronary artery disease and its relationship with treatment strategies and clinical outcomes remained incompletely defined.
Does machine learning-based CT-FFR accurately detect hemodynamically significant ischemia (invasive FFR ≤0.80) and inform revascularization decisions and MACE prognosis in patients with diffuse versus non-diffuse coronary artery disease?
Observational (n=328)
Yes
Does machine learning-based CT-FFR accurately detect hemodynamically significant ischemia (invasive FFR ≤0.80) and inform revascularization decisions and MACE prognosis in patients with diffuse versus non-diffuse coronary artery disease?
Answers are grounded in this paper and cite their sources.
Machine learning-based CT-FFR demonstrates high diagnostic accuracy and strong correlation with invasive FFR in both diffuse and non-diffuse coronary artery disease, supporting its utility as a noninvasive physiological tool for revascularization planning in diffuse lesions.
Background Diffuse coronary artery disease (CAD) is characterized by gradual, long-segment pressure loss, which may not be fully captured by anatomy-based stenosis severity alone. Computed tomography-derived fractional flow reserve (CT-FFR) provides noninvasive physiological assessment, but its performance in diffuse disease and its relationship with treatment strategy and outcomes remain incompletely defined. Purpose To evaluate the agreement and diagnostic performance of machine learning (ML)-based CT-FFR versus invasive pressure wire-based FFR in diffuse versus non-diffuse CAD, and to explore its associations with revascularization decisions and prognosis. Methods This multicenter retrospective study included consecutive patients from 3 hospitals in China. CCTA DICOM datasets and invasive FFR data acquired within 30 days were retrospectively collected. ML-based CT-FFR was centrally computed by offline post-processing in the Keya Medical core laboratory. Diffuse disease was defined as lesion length ≥20 mm (patient-level diffuse: ≥1 diffuse vessel). Vessel-level and patient-level analyses used invasive FFR ≤0.80 as the reference standard. Treatment-decision matching (0.80 threshold) was assessed against actual management, and major adverse cardiovascular events (MACE) were analyzed using Kaplan–Meier and multivariable Cox models. Results Among 328 patients, 136 (41.5%) had diffuse CAD; 374 vessels were included for vessel-level analysis. CT-FFR showed strong correlation with invasive FFR at both vessel and patient levels (vessel: Spearman ρ=0.834, n=374, p<0.001; patient: Spearman ρ=0.828, n=328, p<0.001), with stronger correlations in diffuse than non-diffuse disease. Diagnostic discrimination was excellent overall (AUC 0.941 at both vessel and patient levels) and remained robust in diffuse CAD (patient-level AUC 0.971). Concordance between physiology-guided recommendations and actual revascularization was similar across diffuse and non-diffuse strata, with discordance predominantly driven by nonconcordant revascularization rather than nonconcordant deferral. In 208 patients with follow-up (48 MACE), Kaplan–Meier curves stratified by CT-FFR threshold did not separate significantly, and CT-FFR was not independently associated with MACE in adjusted Cox analysis (HR 1.33 per 0.10-unit change, 95% CI 0.90–1.94; p=0.15), likely reflecting attenuation of baseline physiological risk gradients by downstream revascularization. Conclusions ML-based CT-FFR closely agrees with invasive FFR and maintains strong diagnostic performance in both diffuse and non-diffuse CAD, with particularly favorable performance in diffuse disease. These findings support CT-FFR as a practical noninvasive physiological tool to inform revascularization planning, especially when anatomy alone may underestimate ischemic burden in diffuse lesions.
No takes yet. Share an insight, caveat, or question.
An et al. (2026) conducted an observational in Diffuse and non-diffuse coronary artery disease (CAD) (n=328). Machine learning-based CT-derived fractional flow reserve (ML-based CT-FFR) vs. Invasive pressure wire-based FFR (reference standard ≤0.80) was evaluated on Major adverse cardiovascular events (MACE) and diagnostic agreement/performance against invasive FFR ≤0.80 (HR 1.33, 95% CI 0.90-1.94, p=0.15). ML-based CT-FFR strongly correlated with invasive FFR with high diagnostic accuracy in diffuse CAD, though not independently associated with major cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: